NSAID API Market Report

Global NSAID API Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 24, 2022
  • PAGES：199
  • REPORT CODE：GMM768811
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.

    North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.

    NSAID API market report explains the definition, types, applications, major countries, and major players of the NSAID API market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Actavis

    • Novartis

    • Lonza Group

    • Boehringer Ingelheim

    • BASF

    • Aurobindo Pharma

    • Pfizer

    • Teva Pharmaceutical

    • Mylan

    • Cambrex

    • Zhejiang NHU

    • Hospira

    • Dr Reddy's Laboratories

    • Wuxi Apptec

    By Type:

    • Paracetamol

    • Ibuprofen

    • Aspirin

    • Naproxen

    • Others

    By End-User:

    • Captive Manufacturing

    • Contract Manufacturing

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global NSAID API Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 NSAID API Outlook to 2028- Original Forecasts

    • 2.2 NSAID API Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term NSAID API Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global NSAID API Market- Recent Developments

    • 6.1 NSAID API Market News and Developments

    • 6.2 NSAID API Market Deals Landscape

    7 NSAID API Raw Materials and Cost Structure Analysis

    • 7.1 NSAID API Key Raw Materials

    • 7.2 NSAID API Price Trend of Key Raw Materials

    • 7.3 NSAID API Key Suppliers of Raw Materials

    • 7.4 NSAID API Market Concentration Rate of Raw Materials

    • 7.5 NSAID API Cost Structure Analysis

      • 7.5.1 NSAID API Raw Materials Analysis

      • 7.5.2 NSAID API Labor Cost Analysis

      • 7.5.3 NSAID API Manufacturing Expenses Analysis

    8 Global NSAID API Import and Export Analysis (Top 10 Countries)

    • 8.1 Global NSAID API Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global NSAID API Export by Region (Top 10 Countries) (2017-2028)

    9 Global NSAID API Market Outlook by Types and Applications to 2022

    • 9.1 Global NSAID API Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Paracetamol Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Ibuprofen Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Aspirin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Naproxen Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global NSAID API Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Captive Manufacturing Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Contract Manufacturing Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise NSAID API Market Analysis and Outlook till 2022

    • 10.1 Global NSAID API Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States NSAID API Consumption (2017-2022)

      • 10.2.2 Canada NSAID API Consumption (2017-2022)

      • 10.2.3 Mexico NSAID API Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany NSAID API Consumption (2017-2022)

      • 10.3.2 UK NSAID API Consumption (2017-2022)

      • 10.3.3 Spain NSAID API Consumption (2017-2022)

      • 10.3.4 Belgium NSAID API Consumption (2017-2022)

      • 10.3.5 France NSAID API Consumption (2017-2022)

      • 10.3.6 Italy NSAID API Consumption (2017-2022)

      • 10.3.7 Denmark NSAID API Consumption (2017-2022)

      • 10.3.8 Finland NSAID API Consumption (2017-2022)

      • 10.3.9 Norway NSAID API Consumption (2017-2022)

      • 10.3.10 Sweden NSAID API Consumption (2017-2022)

      • 10.3.11 Poland NSAID API Consumption (2017-2022)

      • 10.3.12 Russia NSAID API Consumption (2017-2022)

      • 10.3.13 Turkey NSAID API Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China NSAID API Consumption (2017-2022)

      • 10.4.2 Japan NSAID API Consumption (2017-2022)

      • 10.4.3 India NSAID API Consumption (2017-2022)

      • 10.4.4 South Korea NSAID API Consumption (2017-2022)

      • 10.4.5 Pakistan NSAID API Consumption (2017-2022)

      • 10.4.6 Bangladesh NSAID API Consumption (2017-2022)

      • 10.4.7 Indonesia NSAID API Consumption (2017-2022)

      • 10.4.8 Thailand NSAID API Consumption (2017-2022)

      • 10.4.9 Singapore NSAID API Consumption (2017-2022)

      • 10.4.10 Malaysia NSAID API Consumption (2017-2022)

      • 10.4.11 Philippines NSAID API Consumption (2017-2022)

      • 10.4.12 Vietnam NSAID API Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil NSAID API Consumption (2017-2022)

      • 10.5.2 Colombia NSAID API Consumption (2017-2022)

      • 10.5.3 Chile NSAID API Consumption (2017-2022)

      • 10.5.4 Argentina NSAID API Consumption (2017-2022)

      • 10.5.5 Venezuela NSAID API Consumption (2017-2022)

      • 10.5.6 Peru NSAID API Consumption (2017-2022)

      • 10.5.7 Puerto Rico NSAID API Consumption (2017-2022)

      • 10.5.8 Ecuador NSAID API Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain NSAID API Consumption (2017-2022)

      • 10.6.2 Kuwait NSAID API Consumption (2017-2022)

      • 10.6.3 Oman NSAID API Consumption (2017-2022)

      • 10.6.4 Qatar NSAID API Consumption (2017-2022)

      • 10.6.5 Saudi Arabia NSAID API Consumption (2017-2022)

      • 10.6.6 United Arab Emirates NSAID API Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria NSAID API Consumption (2017-2022)

      • 10.7.2 South Africa NSAID API Consumption (2017-2022)

      • 10.7.3 Egypt NSAID API Consumption (2017-2022)

      • 10.7.4 Algeria NSAID API Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia NSAID API Consumption (2017-2022)

      • 10.8.2 New Zealand NSAID API Consumption (2017-2022)

    11 Global NSAID API Competitive Analysis

    • 11.1 Actavis

      • 11.1.1 Actavis Company Details

      • 11.1.2 Actavis NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Actavis NSAID API Main Business and Markets Served

      • 11.1.4 Actavis NSAID API Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Novartis

      • 11.2.1 Novartis Company Details

      • 11.2.2 Novartis NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Novartis NSAID API Main Business and Markets Served

      • 11.2.4 Novartis NSAID API Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Lonza Group

      • 11.3.1 Lonza Group Company Details

      • 11.3.2 Lonza Group NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Lonza Group NSAID API Main Business and Markets Served

      • 11.3.4 Lonza Group NSAID API Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Boehringer Ingelheim

      • 11.4.1 Boehringer Ingelheim Company Details

      • 11.4.2 Boehringer Ingelheim NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Boehringer Ingelheim NSAID API Main Business and Markets Served

      • 11.4.4 Boehringer Ingelheim NSAID API Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 BASF

      • 11.5.1 BASF Company Details

      • 11.5.2 BASF NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 BASF NSAID API Main Business and Markets Served

      • 11.5.4 BASF NSAID API Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Aurobindo Pharma

      • 11.6.1 Aurobindo Pharma Company Details

      • 11.6.2 Aurobindo Pharma NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Aurobindo Pharma NSAID API Main Business and Markets Served

      • 11.6.4 Aurobindo Pharma NSAID API Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Pfizer

      • 11.7.1 Pfizer Company Details

      • 11.7.2 Pfizer NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Pfizer NSAID API Main Business and Markets Served

      • 11.7.4 Pfizer NSAID API Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Teva Pharmaceutical

      • 11.8.1 Teva Pharmaceutical Company Details

      • 11.8.2 Teva Pharmaceutical NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Teva Pharmaceutical NSAID API Main Business and Markets Served

      • 11.8.4 Teva Pharmaceutical NSAID API Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Mylan

      • 11.9.1 Mylan Company Details

      • 11.9.2 Mylan NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Mylan NSAID API Main Business and Markets Served

      • 11.9.4 Mylan NSAID API Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Cambrex

      • 11.10.1 Cambrex Company Details

      • 11.10.2 Cambrex NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Cambrex NSAID API Main Business and Markets Served

      • 11.10.4 Cambrex NSAID API Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Zhejiang NHU

      • 11.11.1 Zhejiang NHU Company Details

      • 11.11.2 Zhejiang NHU NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Zhejiang NHU NSAID API Main Business and Markets Served

      • 11.11.4 Zhejiang NHU NSAID API Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Hospira

      • 11.12.1 Hospira Company Details

      • 11.12.2 Hospira NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Hospira NSAID API Main Business and Markets Served

      • 11.12.4 Hospira NSAID API Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Dr Reddy's Laboratories

      • 11.13.1 Dr Reddy's Laboratories Company Details

      • 11.13.2 Dr Reddy's Laboratories NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Dr Reddy's Laboratories NSAID API Main Business and Markets Served

      • 11.13.4 Dr Reddy's Laboratories NSAID API Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Wuxi Apptec

      • 11.14.1 Wuxi Apptec Company Details

      • 11.14.2 Wuxi Apptec NSAID API Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Wuxi Apptec NSAID API Main Business and Markets Served

      • 11.14.4 Wuxi Apptec NSAID API Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    12 Global NSAID API Market Outlook by Types and Applications to 2028

    • 12.1 Global NSAID API Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Paracetamol Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Ibuprofen Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Aspirin Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Naproxen Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global NSAID API Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Captive Manufacturing Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise NSAID API Market Analysis and Outlook to 2028

    • 13.1 Global NSAID API Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States NSAID API Consumption Forecast (2022-2028)

      • 13.2.2 Canada NSAID API Consumption Forecast (2022-2028)

      • 13.2.3 Mexico NSAID API Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany NSAID API Consumption Forecast (2022-2028)

      • 13.3.2 UK NSAID API Consumption Forecast (2022-2028)

      • 13.3.3 Spain NSAID API Consumption Forecast (2022-2028)

      • 13.3.4 Belgium NSAID API Consumption Forecast (2022-2028)

      • 13.3.5 France NSAID API Consumption Forecast (2022-2028)

      • 13.3.6 Italy NSAID API Consumption Forecast (2022-2028)

      • 13.3.7 Denmark NSAID API Consumption Forecast (2022-2028)

      • 13.3.8 Finland NSAID API Consumption Forecast (2022-2028)

      • 13.3.9 Norway NSAID API Consumption Forecast (2022-2028)

      • 13.3.10 Sweden NSAID API Consumption Forecast (2022-2028)

      • 13.3.11 Poland NSAID API Consumption Forecast (2022-2028)

      • 13.3.12 Russia NSAID API Consumption Forecast (2022-2028)

      • 13.3.13 Turkey NSAID API Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China NSAID API Consumption Forecast (2022-2028)

      • 13.4.2 Japan NSAID API Consumption Forecast (2022-2028)

      • 13.4.3 India NSAID API Consumption Forecast (2022-2028)

      • 13.4.4 South Korea NSAID API Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan NSAID API Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh NSAID API Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia NSAID API Consumption Forecast (2022-2028)

      • 13.4.8 Thailand NSAID API Consumption Forecast (2022-2028)

      • 13.4.9 Singapore NSAID API Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia NSAID API Consumption Forecast (2022-2028)

      • 13.4.11 Philippines NSAID API Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam NSAID API Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil NSAID API Consumption Forecast (2022-2028)

      • 13.5.2 Colombia NSAID API Consumption Forecast (2022-2028)

      • 13.5.3 Chile NSAID API Consumption Forecast (2022-2028)

      • 13.5.4 Argentina NSAID API Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela NSAID API Consumption Forecast (2022-2028)

      • 13.5.6 Peru NSAID API Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico NSAID API Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador NSAID API Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain NSAID API Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait NSAID API Consumption Forecast (2022-2028)

      • 13.6.3 Oman NSAID API Consumption Forecast (2022-2028)

      • 13.6.4 Qatar NSAID API Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia NSAID API Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates NSAID API Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria NSAID API Consumption Forecast (2022-2028)

      • 13.7.2 South Africa NSAID API Consumption Forecast (2022-2028)

      • 13.7.3 Egypt NSAID API Consumption Forecast (2022-2028)

      • 13.7.4 Algeria NSAID API Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia NSAID API Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand NSAID API Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of NSAID API

    • Figure of NSAID API Picture

    • Table Global NSAID API Import by Region (Top 10 Countries) (2017-2028)

    • Table Global NSAID API Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Paracetamol Consumption and Growth Rate (2017-2022)

    • Figure Global Ibuprofen Consumption and Growth Rate (2017-2022)

    • Figure Global Aspirin Consumption and Growth Rate (2017-2022)

    • Figure Global Naproxen Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Captive Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Global Contract Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Global NSAID API Consumption by Country (2017-2022)

    • Table North America NSAID API Consumption by Country (2017-2022)

    • Figure United States NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Canada NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Mexico NSAID API Consumption and Growth Rate (2017-2022)

    • Table Europe NSAID API Consumption by Country (2017-2022)

    • Figure Germany NSAID API Consumption and Growth Rate (2017-2022)

    • Figure UK NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Spain NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Belgium NSAID API Consumption and Growth Rate (2017-2022)

    • Figure France NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Italy NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Denmark NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Finland NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Norway NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Sweden NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Poland NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Russia NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Turkey NSAID API Consumption and Growth Rate (2017-2022)

    • Table APAC NSAID API Consumption by Country (2017-2022)

    • Figure China NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Japan NSAID API Consumption and Growth Rate (2017-2022)

    • Figure India NSAID API Consumption and Growth Rate (2017-2022)

    • Figure South Korea NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Pakistan NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Indonesia NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Thailand NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Singapore NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Malaysia NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Philippines NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Vietnam NSAID API Consumption and Growth Rate (2017-2022)

    • Table South America NSAID API Consumption by Country (2017-2022)

    • Figure Brazil NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Colombia NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Chile NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Argentina NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Venezuela NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Peru NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Ecuador NSAID API Consumption and Growth Rate (2017-2022)

    • Table GCC NSAID API Consumption by Country (2017-2022)

    • Figure Bahrain NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Kuwait NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Oman NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Qatar NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia NSAID API Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates NSAID API Consumption and Growth Rate (2017-2022)

    • Table Africa NSAID API Consumption by Country (2017-2022)

    • Figure Nigeria NSAID API Consumption and Growth Rate (2017-2022)

    • Figure South Africa NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Egypt NSAID API Consumption and Growth Rate (2017-2022)

    • Figure Algeria NSAID API Consumption and Growth Rate (2017-2022)

    • Table Oceania NSAID API Consumption by Country (2017-2022)

    • Figure Australia NSAID API Consumption and Growth Rate (2017-2022)

    • Figure New Zealand NSAID API Consumption and Growth Rate (2017-2022)

    • Table Actavis Company Details

    • Table Actavis NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actavis NSAID API Main Business and Markets Served

    • Table Actavis NSAID API Product Portfolio

    • Table Novartis Company Details

    • Table Novartis NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis NSAID API Main Business and Markets Served

    • Table Novartis NSAID API Product Portfolio

    • Table Lonza Group Company Details

    • Table Lonza Group NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lonza Group NSAID API Main Business and Markets Served

    • Table Lonza Group NSAID API Product Portfolio

    • Table Boehringer Ingelheim Company Details

    • Table Boehringer Ingelheim NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim NSAID API Main Business and Markets Served

    • Table Boehringer Ingelheim NSAID API Product Portfolio

    • Table BASF Company Details

    • Table BASF NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table BASF NSAID API Main Business and Markets Served

    • Table BASF NSAID API Product Portfolio

    • Table Aurobindo Pharma Company Details

    • Table Aurobindo Pharma NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurobindo Pharma NSAID API Main Business and Markets Served

    • Table Aurobindo Pharma NSAID API Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer NSAID API Main Business and Markets Served

    • Table Pfizer NSAID API Product Portfolio

    • Table Teva Pharmaceutical Company Details

    • Table Teva Pharmaceutical NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical NSAID API Main Business and Markets Served

    • Table Teva Pharmaceutical NSAID API Product Portfolio

    • Table Mylan Company Details

    • Table Mylan NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan NSAID API Main Business and Markets Served

    • Table Mylan NSAID API Product Portfolio

    • Table Cambrex Company Details

    • Table Cambrex NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cambrex NSAID API Main Business and Markets Served

    • Table Cambrex NSAID API Product Portfolio

    • Table Zhejiang NHU Company Details

    • Table Zhejiang NHU NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zhejiang NHU NSAID API Main Business and Markets Served

    • Table Zhejiang NHU NSAID API Product Portfolio

    • Table Hospira Company Details

    • Table Hospira NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hospira NSAID API Main Business and Markets Served

    • Table Hospira NSAID API Product Portfolio

    • Table Dr Reddy's Laboratories Company Details

    • Table Dr Reddy's Laboratories NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy's Laboratories NSAID API Main Business and Markets Served

    • Table Dr Reddy's Laboratories NSAID API Product Portfolio

    • Table Wuxi Apptec Company Details

    • Table Wuxi Apptec NSAID API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Wuxi Apptec NSAID API Main Business and Markets Served

    • Table Wuxi Apptec NSAID API Product Portfolio

    • Figure Global Paracetamol Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ibuprofen Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Aspirin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Naproxen Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Captive Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NSAID API Consumption Forecast by Country (2022-2028)

    • Table North America NSAID API Consumption Forecast by Country (2022-2028)

    • Figure United States NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe NSAID API Consumption Forecast by Country (2022-2028)

    • Figure Germany NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure France NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC NSAID API Consumption Forecast by Country (2022-2028)

    • Figure China NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure India NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Table South America NSAID API Consumption Forecast by Country (2022-2028)

    • Figure Brazil NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC NSAID API Consumption Forecast by Country (2022-2028)

    • Figure Bahrain NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa NSAID API Consumption Forecast by Country (2022-2028)

    • Figure Nigeria NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania NSAID API Consumption Forecast by Country (2022-2028)

    • Figure Australia NSAID API Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand NSAID API Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US